OA09301A - "New oral dosage form improving bioavailability". - Google Patents

"New oral dosage form improving bioavailability".

Info

Publication number
OA09301A
OA09301A OA59830A OA59830A OA09301A OA 09301 A OA09301 A OA 09301A OA 59830 A OA59830 A OA 59830A OA 59830 A OA59830 A OA 59830A OA 09301 A OA09301 A OA 09301A
Authority
OA
OAPI
Prior art keywords
dosage form
oral dosage
new oral
improving bioavailability
form improving
Prior art date
Application number
OA59830A
Other languages
French (fr)
Inventor
Besancon Denis
Pr Alache Jean-Marc
Dufour Alain
Ecros Fabrice
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Publication of OA09301A publication Critical patent/OA09301A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA59830A 1989-08-07 1990-08-06 "New oral dosage form improving bioavailability". OA09301A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8910605A FR2650502B1 (en) 1989-08-07 1989-08-07 NEW ORAL GALENIC FORM IMPROVING BIOAVAILABILITY

Publications (1)

Publication Number Publication Date
OA09301A true OA09301A (en) 1992-09-15

Family

ID=9384532

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59830A OA09301A (en) 1989-08-07 1990-08-06 "New oral dosage form improving bioavailability".

Country Status (25)

Country Link
EP (1) EP0412877A1 (en)
JP (1) JPH0377819A (en)
KR (1) KR910004181A (en)
CN (1) CN1049455A (en)
AU (1) AU631235B2 (en)
CA (1) CA2022447A1 (en)
CS (1) CS383890A3 (en)
DD (1) DD297332A5 (en)
DE (1) DE4023136A1 (en)
FI (1) FI903885A7 (en)
FR (1) FR2650502B1 (en)
GB (1) GB2234898A (en)
HU (1) HU204997B (en)
IE (1) IE902629A1 (en)
IL (1) IL95105A0 (en)
IN (1) IN170789B (en)
LU (1) LU87777A1 (en)
MA (1) MA21923A1 (en)
NO (1) NO903442L (en)
NZ (1) NZ234593A (en)
OA (1) OA09301A (en)
PE (1) PE491A1 (en)
PT (1) PT94823A (en)
TN (1) TNSN90111A1 (en)
ZA (1) ZA905886B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133633T3 (en) * 1992-01-17 1999-09-16 Alfatec Pharma Gmbh PROCEDURE FOR THE PRODUCTION OF POWDERS, GRANULATES OR PELETS CONTAINING AN ACTIVE SUBSTANCE, WITH A STRUCTURE BASED ON HYDROPHILIC MACROMOLECULES, AND THEIR USE.
DE4221880A1 (en) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Solid and liquid solutions of poorly water-soluble drugs
KR20030089147A (en) * 2002-05-16 2003-11-21 슈라펫 주식회사 Water bottle for pet

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE854414C (en) * 1949-04-26 1952-11-04 Dieter Dr Med Ellenbeck Process for the production of injectable solutions of more or less poorly soluble medicaments
GB715874A (en) * 1952-10-03 1954-09-22 Horlicks Ltd A tablet for use in treating peptic ulcers
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3015611A (en) * 1959-08-25 1962-01-02 Nysco Lab Inc Low density whey-bound tablets
GB1063872A (en) * 1962-08-11 1967-03-30 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical compositions
US3594467A (en) * 1968-10-09 1971-07-20 Richardson Merrell Inc Long-lasting troche
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE3250023T (en) * 1981-01-14 1990-03-29
FR2524312B1 (en) * 1982-04-01 1985-10-04 Tech Cuir Centre NOVEL FORMS OF MICRO-ENCAPSULATION OF DRUG SUBSTANCES BY HOMOGENEOUS LAYERS OF NATIVE COLLAGEN
JPS59101423A (en) * 1982-12-02 1984-06-12 Takada Seiyaku Kk Novel solid pharmaceutical preparation of nifedipine
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4670251A (en) * 1984-05-30 1987-06-02 Igene Biotechnology, Inc. Microcrystalline tableting excipient derived from whey
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IL78017A (en) * 1986-03-03 1989-06-30 Yissum Res Dev Co Sustained release tablets of theophylline
DE3702105A1 (en) * 1987-01-24 1988-08-04 Bayer Ag PARENTERAL SOLUTION
EP0326618A1 (en) * 1987-03-04 1989-08-09 Nippon Hypox Laboratories Incorporated Medicinal composition containing albumin as carrier and process for its preparation
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
DK179687D0 (en) * 1987-04-08 1987-04-08 Farma Food As PREPARATION
ATE90205T1 (en) * 1987-09-08 1993-06-15 Takeda Chemical Industries Ltd WATER-INSOLUBLE CYTOKINS.

Also Published As

Publication number Publication date
HU204997B (en) 1992-03-30
NZ234593A (en) 1993-04-28
CA2022447A1 (en) 1991-02-08
FI903885A0 (en) 1990-08-06
HUT55230A (en) 1991-05-28
KR910004181A (en) 1991-03-28
IL95105A0 (en) 1991-06-10
FR2650502A1 (en) 1991-02-08
FI903885A7 (en) 1991-02-08
TNSN90111A1 (en) 1991-03-05
NO903442L (en) 1991-02-08
DE4023136A1 (en) 1991-02-14
CS276556B6 (en) 1992-06-17
GB2234898A (en) 1991-02-20
FR2650502B1 (en) 1994-05-27
IE902629A1 (en) 1991-02-27
LU87777A1 (en) 1990-12-11
HU904909D0 (en) 1991-01-28
JPH0377819A (en) 1991-04-03
ZA905886B (en) 1991-04-24
CS383890A3 (en) 1992-06-17
IN170789B (en) 1992-05-23
NO903442D0 (en) 1990-08-06
PE491A1 (en) 1991-01-26
GB9017144D0 (en) 1990-09-19
MA21923A1 (en) 1991-04-01
CN1049455A (en) 1991-02-27
AU6023990A (en) 1991-02-07
PT94823A (en) 1991-04-18
AU631235B2 (en) 1992-11-19
EP0412877A1 (en) 1991-02-13
DD297332A5 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
FI872379A7 (en) Process for the preparation of pharmacologically active 1,5-diaryl-3-(ω-substituted-lower-alkyl)-pyrazoles
FI922364A0 (en) PHARMACEUTICAL COMPOSITION.
FI901102A0 (en) PHARMACEUTICAL COMPOSITION.
DE69009315D1 (en) Cinnamamide derivatives.
ITRM910696A0 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL APPLICATION.
ITBO910024A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
FI921134L (en) ORAL ANTICOAGULANT- BLODPLAETTINHIBITORLAOGDOSFORMULERING.
FI922325L (en) ORAL SAMMANSAETTNING FOER BOTNING AV INFLAMMATORISKA TARMKANALSJUKDOMAR.
FI922206A7 (en) Osmotic, oral dosage form for fertility regulation
IT8920486A0 (en) PHARMACEUTICAL COMPOSITIONS.
DE3775802D1 (en) 2- (4'-ALKOXYPHENYL) -5-ALKYLPYRIDINE.
IT8767057A0 (en) LONG-RELEASE PHARMACEUTICAL COMPOSITIONS, RELATIVE DOSAGE FORMS AND PROCEDURE FOR THEIR PREPARATION
FI910088L (en) ORAL PHARMACEUTICAL COMPOSITION.
DE59010722D1 (en) 2,4-dimethyl-6-s-alkylphenols
IT8919074A0 (en) COMPOSITION FOR ORAL HYGIENE.
IT9047924A0 (en) COMPOSITION FOR ORAL HYGIENE.
ITMI910284A1 (en) PROCESS FOR THE PREPARATION OF 2, 2, 6, 6-TETRAMETHY-4-PIPERIDILAMINS
DK360888D0 (en) 3 ', 4'-DINITROGEN SUBSTITUTED EPIPODOPHYLLOTOXING LUCOSIDE DERIVATIVES
IT8920405A0 (en) PHARMACOLOGICALLY ACTIVE AMINOIMIDAZOPYRIDINES.
DK10190A (en) 1,1-DIOXO-CEPHEM-4-CARBOTHIOLIC ACID DERIVATIVES
DE69122555D1 (en) 2,4-Dihydroxyadipic acid derivatives
IT1236969B (en) 3-CYAN-3,5,5'-TRIMETHYL-1-CYCLOHEXANONE PREPARATION PROCEDURE.
FI901277A7 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene PG1z derivatives
DE69002865D1 (en) Oral preparation.
FR2650502B1 (en) NEW ORAL GALENIC FORM IMPROVING BIOAVAILABILITY